Search results for "degenerative diseases"

showing 10 items of 158 documents

Potential Roles of Peroxisomes in Alzheimer's Disease and in Dementia of the Alzheimer's Type

2012

In Alzheimer's disease (AD) and dementia of the Alzheimer's type (DAT), the role played by peroxisomes is not well known. Peroxisomes are present in all eukaryotic cells, with the exception of erythrocytes. They are involved in the β-oxidation process of long-chain fatty acids, very-long-chain fatty acids, and branched-chain fatty acids. They participate in the α-oxidation of phytanic acid, the biosynthesis of bile acids, and the breakdown of eicosanoids. Peroxisomes are also involved in the synthesis of specific fatty acids such as docosahexaenoic acid (DHA), which is essential for the brain and retina, and plasmalogens (PLGN), which play crucial roles in neural cells and are essential com…

carnitine-dependent enzymesPhytanic acidalzheimerplasmalogenMitochondrionBiologyfatty acidsModels Biologicaldhachemistry.chemical_compoundAlzheimer Diseaselipid metabolismPeroxisomesmedicineAnimalsHumansDementianeurodegenerative diseasesperoxisomeCarnitineCognitive declineNeuronsGeneral NeuroscienceBrainGeneral MedicineMetabolismPeroxisomemedicine.diseaseMitochondriaalzheimer; fatty acids; peroxisomes; alzheimer's disease; plasmalogen; dementia; neurodegenerative diseases; dha; peroxisome; lipid metabolism; carnitine-dependent enzymesPsychiatry and Mental healthClinical PsychologychemistryBiochemistryDocosahexaenoic acidalzheimer's diseaseGeriatrics and GerontologyOxidation-Reductiondementiamedicine.drugJournal of Alzheimer's Disease
researchProduct

Role of Adenosine Receptors in Rare Neurodegenerative Diseases with Motor Symptoms

2021

: The approval of istradefylline, an adenosine 2A receptor (A2AR) antagonist, as an addon treatment in adult patients with Parkinson’s disease by the Food and Drug Administration (FDA) and European Medicines Agency (EMA), is the latest proof of the importance of the adenosinergic system in the nervous system. Adenosine is an endogenous purine nucleoside with a role as a modulator of both neurotransmission and the inflammatory response. As such, the expression pattern of the 4 adenosine receptors (A1R, A2AR, A2BR and A3R) and the extracellular adenosine levels have attracted great interest in the pathogenesis and possible treatment of rare neurodegenerative diseases with motor symptoms. The…

congenital hereditary and neonatal diseases and abnormalitiesbusiness.industryNeurodegenerationNeurodegenerative DiseasesCell BiologyGeneral MedicineAdenosinergicIstradefyllinemedicine.diseaseBioinformaticsBiochemistryAdenosine receptorAdenosinechemistry.chemical_compoundchemistrymedicineSpinocerebellar ataxiaAmyotrophic lateral sclerosisbusinessMolecular BiologyMachado–Joseph diseasemedicine.drugCurrent Protein & Peptide Science
researchProduct

From Dysbiosis to Neurodegenerative Diseases through Different Communication Pathways: An Overview

2023

The microbiome research field has rapidly evolved over the last few decades, becoming a major topic of scientific and public interest. The gut microbiota (GM) is the microbial population living in the gut. The GM has many functions, such as maintaining gut homeostasis and host health, providing defense against enteric pathogens, and involvement in immune system development. Several studies have shown that GM is implicated in dysbiosis and is presumed to contribute to neurodegeneration. This review focuses mainly on describing the connection between the intestinal microbiome alterations (dysbiosis) and the onset of neurodegenerative diseases to explore the mechanisms that link the GM to nerv…

gut microbiotaGeneral Immunology and MicrobiologySettore BIO/16 - Anatomia Umanadysbiosigut microbiomeneurodegenerative diseasesGeneral Agricultural and Biological SciencesGeneral Biochemistry Genetics and Molecular BiologyBiology
researchProduct

Golgi Fragmentation in Neurodegenerative Diseases: Is There a Common Cause?

2019

In most mammalian cells, the Golgi complex forms a continuous ribbon. In neurodegenerative diseases, the Golgi ribbon of a specific group of neurons is typically broken into isolated elements, a very early event which happens before clinical and other pathological symptoms become evident. It is not known whether this phenomenon is caused by mechanisms associated with cell death or if, conversely, it triggers apoptosis. When the phenomenon was studied in diseases such as Parkinson’s and Alzheimer’s or amyotrophic lateral sclerosis, it was attributed to a variety of causes, including the presence of cytoplasmatic protein aggregates, malfunctioning of intracellular traffic and/or alterations i…

intracellular transportProgrammed cell deathGolgi ApparatusReviewProtein aggregationBiologyProtein Aggregation Pathologicalsymbols.namesakeMicemedicineAnimalsHumansAmyotrophic lateral sclerosisFragmentation (cell biology)Cytoskeletonlcsh:QH301-705.5NeuronscytoskeletonNeurodegenerative DiseasesGeneral MedicineGolgi apparatusmedicine.diseaseprotein aggregatesGolgi complexlcsh:Biology (General)ApoptosissymbolsNeuroscienceIntracellularCells
researchProduct

Role of Peripheral Immune Cells-Mediated Inflammation on the Process of Neurodegenerative Diseases

2020

Neurodegenerative diseases are characterized by progressive loss of selectively vulnerable neuronal populations, which contrasts with selectively static loss of neurons due to toxic or metabolic disorders. The mechanisms underlying their progressive nature remain unknown. To date, a timely and well-controlled peripheral inflammatory reaction is verified to be essential for neurodegenerative diseases remission. The influence of peripheral inflammation on the central nervous system is closely related to immune cells activation in peripheral blood. The immune cells activation participated in the uncontrolled and prolonged inflammation that drives the chronic progression of neurodegenerative di…

lcsh:Immunologic diseases. AllergyCentral Nervous System0301 basic medicinedendritic cellT-LymphocytesT cellImmunologyCentral nervous systemInflammationReviewmacrophageNatural killer cell03 medical and health sciences0302 clinical medicineImmune systemAnimalsHumansImmunology and AllergyMedicineMacrophageB cellInflammationB-LymphocytesB cellbusiness.industryMacrophagesT cellNeurodegenerative DiseasesDendritic cellnatural killer cellKiller Cells Natural030104 developmental biologymedicine.anatomical_structuremonocyteImmunologyNeurogenic Inflammationmedicine.symptomlcsh:RC581-607peripheral immune cellsbusiness030215 immunologyFrontiers in Immunology
researchProduct

Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Human.

2013

Animal studies point to an implication of the endocannabinoid system on executive functions. In humans, several studies have suggested an association between acute or chronic use of exogenous cannabinoids (Δ9-tetrahydrocannabinol) and executive impairments. However, to date, no published reports establish the relationship between endocannabinoids, as biomarkers of the cannabinoid neurotransmission system, and executive functioning in humans. The aim of the present study was to explore the association between circulating levels of plasma endocannabinoids N-arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) and executive functions (decision making, response inhibition and cognit…

lcsh:MedicineNeuropsychological TestsSocial and Behavioral SciencesPrefrontal cortexReceptores de cannabinoides:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Executive FunctionEndocrinologyCognitionWisconsin Card Sorting TestEndocrinologiaHuman PerformanceMedicinePsychologyendocannabinoid systemPrefrontal cortexlcsh:ScienceProblem SolvingPsychiatryMultidisciplinaryCognitive NeurologyCognitive flexibilityPresa de decisionsCognitionMiddle AgedExecutive functionsexecutive functionsHumanos2-arachidonoylglycerolSubstance abuseEndocannabinoidesMental HealthNeurologyCognicióMedicineFemalelipids (amino acids peptides and proteins):Chemicals and Drugs::Amino Acids Peptides and Proteins::Proteins::Membrane Proteins::Receptors Cell Surface::Receptors G-Protein-Coupled::Receptors Cannabinoid [Medical Subject Headings]Animal behaviorClinical psychology:Chemicals and Drugs::Lipids::Fatty Acids::Fatty Acids Unsaturated::Arachidonic Acids [Medical Subject Headings]HumanResearch ArticleAdultN-arachidonoylethanolamine:Psychiatry and Psychology::Mental Disorders::Substance-Related Disorders::Marijuana Abuse [Medical Subject Headings]Polyunsaturated AlkamidesCognitive NeuroscienceDecision MakingArachidonic AcidsGlyceridesYoung AdultCannabinoides -- ReceptorsNeuropsychologyCànnabis:Diseases::Nervous System Diseases::Neurodegenerative Diseases [Medical Subject Headings]Pruebas neuropsicológicasÁcidos araquidónicosHumansFunción ejecutivaBiologyCannabisCannabinoides -- Efectes fisiològics:Anatomy::Nervous System::Central Nervous System [Medical Subject Headings]Behavior:Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Molecular Mechanisms of Pharmacological Action::Neurotransmitter Agents::Endocannabinoids [Medical Subject Headings]business.industrylcsh:RCognitive Psychologymedicine.diseaseIowa gambling taskEnfermedades neurodegenerativasAbuso de marihuanaSistema nervioso central:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Neuropsychological Tests [Medical Subject Headings]:Psychiatry and Psychology::Psychological Phenomena and Processes::Mental Processes::Executive Function [Medical Subject Headings]lcsh:QbusinessDecision makingStroop effectNeuroscienceEndocannabinoids
researchProduct

Will it ever become possible to prevent dopaminergic neuronal degeneration?

2008

Parkinsons disease (PD) is the second leading age-related degenerative brain disease in the world affecting millions of people. This neurological disorder disrupts the quality of life of patients and their families, exerts an enormous emotional and physical strain on caregivers, and has a large cost for society. Moreover, the increasing numbers of elderly people in the population will result in a sharp increase in the prevalence of PD. The understanding of its pathophysiology and treatment has advanced at a very impressive rate during past decades. Nevertheless, PD is still fatal and there is at present no cure for it. Furthermore, there are no proven therapies for prevention of PD and alth…

medicine.medical_specialtyDopaminePopulationNeurological disorderDiseaseNeuroprotectionSettore BIO/09 - FisiologiaNeuroprotective agentsRisk FactorsmedicineAnimalsHumansNeuronal degenerationNeurodegeneration Neuroprotection Parkinson's diseaseIntensive care medicineeducationPharmacologyNeuronseducation.field_of_studyCell Deathbusiness.industryGeneral NeuroscienceDopaminergicNeurodegenerative DiseasesParkinson's disease -- Treatmentmedicine.diseaseBrain diseaseNeuroprotective AgentsDrug developmentbusinessNervous system -- Degeneration
researchProduct

Japanese, Mediterranean and Argentinean diets and their potential roles in neurodegenerative diseases

2019

Environmental factors are responsible of cellular senescence and processes found in the development of cognitive disorders. The aim of this paper is to compare benefits of the Japanese, Mediterranean, and Argentinian Diet on the onset or prevention of senile dementia (SD) and Alzheimer's Disease (AD). Special focus was on the effects of specific compounds such as polyunsaturated fatty acids (PUFAs), antioxidants, and saturated and trans fatty acids. A high adherence to diets rich in PUFAs, monounsaturated fatty acids (MUFAs) and antioxidants may decrease the risk of developing neurodegenerative diseases ; while the predominance of saturated and trans fatty acids possibly rises it.

medicine.medical_specialtyMediterranean diet030309 nutrition & dieteticsArgentinaCellular senescenceDiseaseBiologySenile dementiaDiet MediterraneanNeuroprotection03 medical and health sciences0404 agricultural biotechnologyJapanAlzheimer DiseaseInternal medicinealzheimer's disease ; neuroprotection ; mediterranean diet ; japanese style diet ; food patternmedicineHumanschemistry.chemical_classification0303 health sciencesMediterranean RegionNeurodegenerative Diseases04 agricultural and veterinary sciences040401 food scienceNeuroprotectionDietEndocrinologychemistryFatty Acids UnsaturatedDementiaFood SciencePolyunsaturated fatty acidFood Research International
researchProduct

Perturbed Glucose Metabolism: Insights into Multiple Sclerosis Pathogenesis

2014

Multiple sclerosis (MS) is a complex debilitating disease of the central nervous system perceived to result from the autoimmune effect of T cells in damaging myelin sheath. However, the exact pathogenesis of the disease remains elusive. Initial studies describing the possibility of defective pyruvate metabolism in MS were performed in 1950s. The group observed elevated blood pyruvate level in both fasting and postprandial times in MS patients with relapse. Similarly, other investigators also reported increased fasting pyruvate level in this disease. These reports hint to a possible abnormality of pyruvate metabolism in MS patients. In addition, increase in levels of Krebs cycle acids like a…

medicine.medical_specialtyMini ReviewCentral nervous systemDiseaseCarbohydrate metabolismBioinformaticsmultiple sclerosislcsh:RC346-429PathogenesisInternal medicinebrain glucose metabolismmedicineneurodegenerative diseaseslcsh:Neurology. Diseases of the nervous systemmitochondrial defectsbusiness.industryMultiple sclerosisand neurodegenerative diseasesmedicine.diseasecell-specific mechanismsReview articleCitric acid cycleMetabolic pathwaymedicine.anatomical_structureEndocrinologyNeurologyNeurology (clinical)businessNeuroscienceFrontiers in Neurology
researchProduct

Neurophysiological evaluation of visual function in iRBD: potential role in stratifying RBD conversion risk.

2021

Abstract Study objectives To evaluate neurophysiological alterations of visual function in idiopathic REM sleep Behavior Disorder (iRBD) both as markers and predictors of neurodegenerative disorders. Methods In a longitudinal follow-up study of 46 consecutive iRBD patients (follow-up duration 8.4 ± 3.4 years), the baseline parameters in luminance-contrast pattern (VEPp), red-green color (VEPc) and motion-onset (VEPm) Visual Evoked Potentials in iRBD were compared to early (ePD) and advanced (aPD) Parkinson's Disease subjects. Parameters of latency and amplitude of iRBD converters to neurodegenerative disease were compared with those of the non-converters. Results The VEP P100 mean latency v…

medicine.medical_specialtyParkinson's diseasegenetic structuresEvoked potentials; Neurodegenerative disorders; Neurophysiology; Parkinson's disease; Phenoconversion risk; REM sleep Behavior disorderParkinson's diseaseNeurophysiologyVisual evoked potentialsREM Sleep Behavior DisorderAudiologyREM sleep behavior disorder03 medical and health sciences0302 clinical medicinemedicineHumansbusiness.industryNeurodegenerative DiseasesParkinson DiseaseGeneral MedicineEvoked potentialsNeurophysiologymedicine.disease030228 respiratory systemVisual functionNeurodegenerative disordersEvoked Potentials VisualPhenoconversion riskbusiness030217 neurology & neurosurgeryFollow-Up StudiesSleep medicine
researchProduct